The effectiveness of very slow switching to aripiprazole in schizophrenia patients with dopamine supersensitivity psychosis: a case series from an open study-Reference-Cited by-同舟云学术

The effectiveness of very slow switching to aripiprazole in schizophrenia patients with dopamine supersensitivity psychosis: a case series from an open study

Published:2020-08-28 Issue:6 Volume:35 Page:338-344
ISSN:0268-1315
Container-title:International Clinical Psychopharmacology
language:en
Short-container-title:

Author:

Kanahara Nobuhisa,Takase Masayuki,Sasaki Tsuyoshi,Honma Masanori,Fujita Yasutaka,Tadokoro Shigenori,Suzuki Hitoshi,Yamanaka Hiroshi,Noda Shingo,Yanahashi Satoshi,Saiga Takahisa,Komatsu Naoya,Simoyama Takeshi,Iyo Masaomi

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Psychiatry and Mental health

Reference29 articles.

1. Aripiprazole in combination with other antipsychotic drugs may worsen psychosis.;Adan-Manes;J Clin Pharm Ther,2009

2. Comparative study of treatment continuation using second-generation antipsychotics in patients with schizophrenia or schizoaffective disorder.;Azekawa;Neuropsychiatr Dis Treat,2011

3. Switching patients to aripiprazole from other antipsychotic agents: a multicenter randomized study.;Casey;Psychopharmacology (Berl),2003

4. Severe cases of neuroleptic-induced supersensitivity psychosis. Diagnostic criteria for the disorder and its treatment.;Chouinard;Schizophr Res,1991

5. Atypical antipsychotics: CATIE study, drug-induced movement disorder and resulting iatrogenic psychiatric-like symptoms, supersensitivity rebound psychosis and withdrawal discontinuation syndromes.;Chouinard;Psychother Psychosom,2008

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Can brexpiprazole be switched safely in patients with schizophrenia and dopamine supersensitivity psychosis? A retrospective analysis in a real-world clinical practice;Journal of Psychopharmacology;2023-07-03

2. Efficacy of Asenapine in Drug-resistant Psychotic Patients with Dopamine Supersensitivity Psychosis: Two Cases;Clinical Psychopharmacology and Neuroscience;2023-02-28

3. The dilemma of polypharmacy in psychosis: is it worth combining partial and full dopamine modulation?;International Clinical Psychopharmacology;2022-07-12

4. Editorial;International Clinical Psychopharmacology;2022-03-31

5. Case series on aripiprazole and dopamine supersensitivity psychosis;International Clinical Psychopharmacology;2022-02-07